Clinical Trial Update: A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial of maintenance Fluzoparib versus placebo in relapsed ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Fluzoparib (fluzoparib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED